Josh Pan, Phd Email and Phone Number
Josh Pan, Phd work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Josh Pan, Phd personal email
- Valid
- Valid
Josh Pan, Phd phone numbers
I am a biotech executive with experience across start-ups, high growth businesses, and IPOs. My work in start-ups, combined with my training in science, has given me a diverse skillset that spans business development, fundraising, corporate communications, medical affairs, and new product planning. I enjoy jumping wherever I can help advance the science and the strategy.Specific Contributions and Key Highlights:• Financing from early angel investing to venture capital to crossover to IPO• Business development and strategic partnerships • Financial modeling and drug launch forecasting • Competitive landscape and market opportunity assessments• Corporate communications, including investor relations and public relations• Corporate branding and rebranding, including mission, vision, and culture setting • Crisis management• Drug development from preclinical to IND filing to late-stage clinical trials• Clinical trials branding and recruitment• Medical affairs, including scientific communications, external engagement with KOLs and patient advocacy groups• Commercial preparedness for new drug launch, including non-proprietary and brand naming, and non-promotional marketing/disease-state education• Lead or co-author on scientific presentations and publications
-
Chief Business OfficerLandmark Bioventures AgKirkland, Wa, Us
-
Chief Business OfficerLandmark Bioventures Ag Jun 2024 - PresentBasel, ChLandmark BioVentures AG is an integrated and agile biotech hub-and-spoke company. We take a unique model focused on lean approaches and smart resource allocation leading to our diversified yet complementary Nexus of 7 companies developing 10 first in class therapeutics.As CBO, I lead corporate and business strategy, business development, fundraising, and corporate communications including public and investor relations for LBV while supporting in leadership and operational roles with our Nexus companies. -
PrincipalS-Phase Ventures 2015 - PresentSeattle, Wa, UsI founded this consultancy supporting start-ups, non-profits, and venture funds with commercial assessment, business development, due diligence, investor relations, and fundraising. Since 2015, I have engaged with 15 clients, most notably Bellevue Capital Management, WiBotic, and W Fund. As a Partner of Bellevue Capital Management, I supported our $70 million SPAC IPO, shaped the new company’s business strategy, identified life sciences investment opportunities, and secured strategic partnerships. -
Vice President, Corporate Development And External AffairsAthira Pharma 2023 - 2023Bothell, Washington, UsI was responsible for corporate strategy, partnering, investor and public relations, scientific communications, and commercial planning at this clinical stage biopharma company focused on developing medicines for neurodegenerative diseases. I built awareness of our lead asset’s novel mechanism of action in the scientific community by developing a comprehensive medical affairs strategy. I led launch planning, designing the go-to-market strategy and initiating creative content development for an unbranded marketing campaign. -
Vice President, Corporate DevelopmentAthira Pharma 2022 - 2023Bothell, Washington, UsIn addition to establishing our scientific advisory board, I supported recruitment efforts for our Phase 2/3 clinical trial. I directed a variety of tactics to raise awareness with patients, caregivers, advocacy groups, and physicians, including digital advertising, podcast features, and social media.
-
Senior Director Of Business DevelopmentAthira Pharma 2020 - 2022Bothell, Washington, UsI was responsible for business development, corporate communications, investor relations, and market readiness. I spearheaded the company’s external crisis response during a scientific misconduct scandal and proxy fight with activist shareholders. I crafted messaging to investors, clinical investigators, patient advocacy groups, and the public to overcome scientific credibility challenges and restore confidence. I also contributed to the success of Athira's $104 million follow-on offering by creating corporate presentations and orchestrating presentations at investor conferences, among other activities.
-
Director Of Business DevelopmentAthira Pharma 2015 - 2020Bothell, Washington, UsI joined what was then known as M3 Biotechnology as employee #3. I was responsible for business development, corporate communications, and investor relations – as well as any other work that needed to be done at this start-up. During this period, the company’s value grew from $50 to $670 million. I contributed to this 13x increase in valuation by helping to raise the money we needed to advance our lead asset from preclinical development through Phase 1 trials. Our clinical development success set the stage for our IPO in 2020. In all, I helped raise more than $300 million, tapping grant funding, venture funding, and eventually major biotech investors.
-
Partner Relations ManagerComotion 2015 - 2015Seattle, Washington, UsI advised start-up teams on early commercialization strategy and investor messaging at the University of Washington’s technology transfer office. To support start-up formation, I coordinated matching of start-ups with mentors. I grew the mentoring program 20% by improving outreach to entrepreneurs. -
Business Development OfficerComotion 2014 - 2015Seattle, Washington, UsIn this role, I sourced deals, conducted diligence, and advanced Seattle’s innovation ecosystem. I facilitated private investments totaling $800,000 in 20 spinout companies by organizing an innovation open house that was attended by 300+ investors, faculty, students, and entrepreneurs.
-
Bridge Fund AssociateThe W Fund 2013 - 2014Seattle, Washington, UsI managed fund operations, strategic alliances, outreach, marketing, and event planning for this early-stage venture fund established to accelerate the success of technology start-ups by providing seed capital. I advised portfolio companies and sourced, evaluated, and negotiated new deals. During my tenure, we closed 10 investments totaling $4 million which have returned millions to date. I also catalyzed $1.5 million investment in portfolio companies by creating a new angel investment group and increasing external awareness of Washington start-ups.
Josh Pan, Phd Skills
Josh Pan, Phd Education Details
-
University Of WashingtonNeuroscience -
University Of Washington Bothell School Of BusinessBusiness Administration
-
Oregon State UniversityScience Chemistry; Forensics Science
-
Lancaster UniversityStudy Abroad
Frequently Asked Questions about Josh Pan, Phd
What company does Josh Pan, Phd work for?
Josh Pan, Phd works for Landmark Bioventures Ag
What is Josh Pan, Phd's role at the current company?
Josh Pan, Phd's current role is Chief Business Officer.
What is Josh Pan, Phd's email address?
Josh Pan, Phd's email address is jo****@****bio.com
What is Josh Pan, Phd's direct phone number?
Josh Pan, Phd's direct phone number is +150349*****
What schools did Josh Pan, Phd attend?
Josh Pan, Phd attended University Of Washington, University Of Washington Bothell School Of Business, Oregon State University, Lancaster University.
What skills is Josh Pan, Phd known for?
Josh Pan, Phd has skills like Molecular Biology, Statistics, Cell Biology, Research Design, Biochemistry, Confocal Microscopy, Laboratory, Grant Writing, Immunofluorescence, Market Research, Neuroscience, Data Analysis.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial